• Thumbnail for Buspirone
    Buspirone, sold under the brand name Buspar, among others, is an anxiolytic, a medication primarily used to treat anxiety disorders, particularly generalized...
    42 KB (3,693 words) - 07:14, 1 July 2024
  • Side effects of buspirone by incidence include: Very common (>10% incidence) Dizziness/lightheadedness Headache Somnolence (sleepiness) Common (1–10%...
    4 KB (344 words) - 23:07, 27 January 2024
  • Buspirone/testosterone (tentative brand name Lybridos) is a combination of buspirone, a 5-HT1A receptor partial agonist, α2-adrenergic receptor antagonist...
    5 KB (321 words) - 12:18, 13 November 2023
  • Thumbnail for Pyrimidinylpiperazine
    A number of pyrimidinylpiperazine derivatives are drugs, including: Buspirone – anxiolytic Dasatinib – anticancer agent Eptapirone – anxiolytic Gepirone –...
    7 KB (520 words) - 13:23, 12 March 2024
  • anxiety disorders due to their fast onset but carry the risk of dependence. Buspirone is indicated for GAD, which has much slower onset but with the advantage...
    46 KB (4,394 words) - 12:30, 14 July 2024
  • to moderate cerebellar ataxia may be treatable with buspirone. It is thought that the buspirone increases the serotonin levels in the cerebellum and...
    11 KB (1,047 words) - 13:05, 29 December 2023
  • Thumbnail for Azapirone
    (S-20,499) Binospirone (MDL-73,005) BMY-7,378 (CAS number: 21102-95-4 ) Buspirone (Buspar) Enilospirone (CERM-3,726) Eptapirone (F-11,440) Gepirone (Exxua)...
    27 KB (2,701 words) - 16:17, 8 June 2024
  • Thumbnail for Gepirone
    the D2 receptor (30- to 50-fold lower in comparison to buspirone). However, similarly to buspirone, gepirone metabolizes into 1-(2-pyrimidinyl)piperazine...
    17 KB (1,469 words) - 19:00, 27 March 2024
  • Thumbnail for Agonist
    specific type of receptor. E.g. buspirone is a selective agonist for serotonin 5-HT1A. Partial agonists (such as buspirone, aripiprazole, buprenorphine,...
    14 KB (1,622 words) - 00:36, 7 July 2024
  • Thumbnail for 5-HT1A receptor
    5-HT1A receptor agonists like buspirone and flesinoxan show efficacy in relieving anxiety and depression. Buspirone and tandospirone are currently approved...
    58 KB (6,124 words) - 07:32, 3 June 2024